EUVIMEDEUVIMED entdecken
Kohortenstudie

Absolute and time-varying mortality according to qualitative pretreatment alpha-fetoprotein status in hepatocellular carcinoma: a SEER cohort study

Jianlin Wu, Haijie Hu, Fuyu Li

European Journal of Surgical Oncology · 2027-01 · 53 (1) · 112339

DOI: 10.1016/j.ejso.2026.112339 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Surgical Oncology, 2027-01. Verfasst von Jianlin Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. Electronic addr…. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Sichuan University West China Hospital, Sichuan Provincial Natural Science Foundation, Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Registry-recorded qualitative alpha-fetoprotein (AFP) status may aid prognostic assessment in hepatocellular carcinoma (HCC), but a constant hazard ratio obscures absolute mortality burden, competing causes, and changes over time. MATERIALS AND METHODS: We studied adults with HCC diagnosed during 2010-2015 in the Surveillance, Epidemiology, and End Results database. Index records were selected before AFP classification. Diagnosis-time-adjusted Cox models, AFP-negative-targeted matching, 60-month restricted mean survival time (RMST), cause-specific restricted mean time lost (RMTL), observation weighting, and flexible time-effect analyses were used. RESULTS: Among 24,234 adults, 17,500 were AFP-positive and 6734 were AFP-negative. Adjusted hazard ratios (HRs) for AFP-negative versus AFP-positive status were 0.729 (95% CI 0.705-0.755) for all-cause mortality and 0.682 (0.657-0.709) for HCC-specific mortality; matched HRs in 6650 pairs were 0.795 (0.766-0.825) and 0.745 (0.715-0.777). AFP-negative patients had 5.73 additional months of overall RMST (5.02-6.45). AFP-positive patients lost 6.31 additional months to HCC death (5.55-7.08), with a 9.40-percentage-point higher five-year HCC-death incidence (7.78-10.97). Observation weighting and histology restriction yielded similar estimates. Piecewise HRs showed lower conditional mortality with AFP negativity during 0-12 and > 12-36 months, near-null associations during >36-60 months, and HRs above 1 during >60-120 months. CONCLUSION: Qualitative AFP status distinguished early and five-year HCC mortality burden, but the relative association was not maintained throughout follow-up. These registry estimates support prognosis and case-mix interpretation, not treatment selection.

Schlagwörter

Stichwörter der Autor:innen

Alpha-fetoproteinCompeting risksHepatocellular carcinomaNonproportional hazardsRestricted mean survival timeSEER

Autor:innen und Institutionen

  • Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. Electronic address: wjl2019@163.com.
  • Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. Electronic address: hhj1063557621@163.com.
  • Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. Electronic address: lfy_74@hotmail.com.

Förderung

  • Sichuan University West China Hospital
  • Sichuan Provincial Natural Science Foundation
  • Sichuan Province Science and Technology Support Program

Zitieren

APA

Wu, J., Hu, H., & Li, F. (2027). Absolute and time-varying mortality according to qualitative pretreatment alpha-fetoprotein status in hepatocellular carcinoma: a SEER cohort study. European Journal of Surgical Oncology, 53(1), 112339. https://doi.org/10.1016/j.ejso.2026.112339

Vancouver

Wu J, Hu H, Li F. Absolute and time-varying mortality according to qualitative pretreatment alpha-fetoprotein status in hepatocellular carcinoma: a SEER cohort study. European Journal of Surgical Oncology. 2027;53(1):112339. doi:10.1016/j.ejso.2026.112339

BibTeX
@article{Wu2027,
  author = {Wu, Jianlin and Hu, Haijie and Li, Fuyu},
  title = {Absolute and time-varying mortality according to qualitative pretreatment alpha-fetoprotein status in hepatocellular carcinoma: a SEER cohort study},
  journal = {European Journal of Surgical Oncology},
  year = {2027},
  volume = {53},
  number = {1},
  pages = {112339},
  doi = {10.1016/j.ejso.2026.112339}
}
Kostenlos starten →